Evidence map›Paper›PMID 28445754›Full record

ArticleBiophysical journal2017

Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.

Laura M Haynes, Thomas Orfeo, Kenneth G Mann, Stephen J Everse, Kathleen E Brummel-Ziedins

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Laura M HaynesDepartment of Biochemistry, Robert Larner M.D. College of Medicine, University of Vermont, Colchester, Vermont.
Thomas OrfeoDepartment of Biochemistry, Robert Larner M.D. College of Medicine, University of Vermont, Colchester, Vermont.
Kenneth G MannHaematologic Technologies, Essex Junction, Vermont.
Stephen J EverseDepartment of Biochemistry, Robert Larner M.D. College of Medicine, University of Vermont, Colchester, Vermont.
Kathleen E Brummel-ZiedinsDepartment of Biochemistry, Robert Larner M.D. College of Medicine, University of Vermont, Colchester, Vermont. Electronic address: kathleen.brummel@uvm.edu.
University of Vermont · USHaematologic Technologies (United States) · US

Funding

Analysis and Characterization of Trauma-Induced CoagulopathyUM1HL120877 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MORRISSEY, JAMES H., WISNIEWSKI, STEPHEN R · 2013 to 2019
$26.6M
INVERTED LASER-SCANNING CONFOCAL MICROSCOPE: LUNG RESEARCHS10RR019246 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TAATJES, DOUGLAS J. · 2004 to 2004
$473k
NCRR NIH HHS S10 RR019246NHLBI NIH HHS UM1 HL120877
6 · The paper itself

Abstract

In closed system models of fibrin formation, exosite-mediated thrombin binding to fibrin contributes to clot stability and is resistant to inhibition by antithrombin/heparin while still susceptible to small, active-site inhibitors. Each molecule of fibrin can bind ∼1.6 thrombin molecules at low-affinity binding sites (K

Indexed as

AntithrombinsBlood CoagulationDabigatranFibrinFibrinogenFibrinolytic AgentsHemodynamicsHeparinHumansKineticsMicroscopy, ConfocalMicroscopy, Electron, ScanningModels, CardiovascularModels, MolecularThrombinVeinsAntithrombinsDabigatranFibrinFibrinogenFibrinolytic AgentsHeparinThrombin

Identifiers

PMID28445754
PMCPMC5406282
OpenAlexW2608928161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.